ABVC BioPharma, Inc. Payments of Stock Issuance Costs
ABVC BioPharma, Inc. (ABVC) reported Payments of Stock Issuance Costs of $850.43 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-31.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2023-03-31
- ABVC BioPharma, Inc. payments of stock issuance costs for the quarter ending 2021-12-31 was $0.00.
- ABVC BioPharma, Inc. payments of stock issuance costs for fiscal 2021 was $850.43K.
| Period end | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 9 month | Payments of Stock Issuance Costs 12 month |
|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $850.43K 10-K · filed 2023-03-31 | |
| 2021-09-30 | $850.43K 10-Q · filed 2022-11-14 |